observed.

Specifically, the percentage reduction in dihydrotestosterone does

not increase linearly with each incremental increase in dosage, as evidenced
by the lack of a consistent pattern in the reduction percentages observed at
each dosage level. The trend is one of gradual increase, with a slight incline
observed as the dosage escalates from 0.2mg to 5mg. The reduction of DHT
may result in adverse effects such as sexual side effects or decreased
motivation.

The prolonged use of Finasteride is purported to mitigate hair loss and

promote hair growth. However, a common concern with Finasteride usage is
the initial administration of low doses such as 0.1 or 0.2mg, which results in a
reduction of Dihydrotestosterone (DHT). Due to the extended duration of the
anagen phase, individuals may not observe significant changes in their hair
growth during the initial month of treatment. Subsequently, upon increasing
the dosage, the individual encounters a heightened occurrence of adverse
reactions. The topical application of 0.25% finasteride in a quantity of one
milliliter can produce equivalent results to the oral administration of 2.5mg of
finasteride. Research has shown that a concentration of 0.2 mg of finasteride
in the bloodstream has the ability to promote the growth of new hair while
simultaneously preserving existing hair [39].

The correlation between dosage and side effects of Finasteride is observed to

be positive, with some individuals exhibiting heightened sensitivity to the drug.
The recommended dosage of Finasteride, as supported by medical
professionals and clinical research, is typically within the range of 0.5 to 1
milligram per day, administered orally in tablet form, and has been